Literature DB >> 23964680

Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia.

Kamran M A Aziz1.   

Abstract

Ramadan fasting is an obligatory duty for Muslims. Unique physiologic and metabolic changes occur during fasting which requires adjustments of diabetes medications. Although challenging, successful fasting can be accomplished if pre-Ramadan extensive education is provided to the patients. Current research was conducted to study effective Ramadan fasting with different OHAs/insulins without significant risk of hypoglycemia in terms of HbA1c reductions after Ramadan. ANOVA model was used to assess HbA1c levels among different education statuses. Serum creatinine was used to measure renal functions. Pre-Ramadan diabetes education with alteration of therapy and dosage adjustments for OHAs/insulin was done. Regression models for HbA1c before Ramadan with FBS before sunset were also synthesized as a tool to prevent hypoglycemia and successful Ramadan fasting in future. Out of 1046 patients, 998 patients fasted successfully without any episodes of hypoglycemia. 48 patients (4.58%) experienced hypoglycemia. Χ(2) Test for CRD/CKD with hypoglycemia was also significant (p-value < 0.001). Significant associations and linear regression were found for HbA1c and sunset FBS; RBS post-dawn with RBS mid-day and FBS at sunset. The proposed regression models of this study can be used as a guide in future for Ramadan diabetes management. Some relevant patents are also outlined in this paper.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23964680     DOI: 10.2174/18715303113139990010

Source DB:  PubMed          Journal:  Recent Pat Endocr Metab Immune Drug Discov        ISSN: 1872-2148


  6 in total

1.  Severe hypoglycemia in the Look AHEAD Trial.

Authors:  Frank L Greenway
Journal:  J Diabetes Complications       Date:  2016-03-17       Impact factor: 2.852

Review 2.  Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients.

Authors:  Kamran Ma Aziz
Journal:  Diabetes Metab Syndr Obes       Date:  2015-04-16       Impact factor: 3.168

Review 3.  Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan.

Authors:  Anja Schweizer; Serge Halimi; Sylvie Dejager
Journal:  Vasc Health Risk Manag       Date:  2013-12-24

4.  A prospective multi-country observational trial to compare the incidences of diabetic ketoacidosis in the month of Ramadan, the preceding month, and the following month (DKAR international).

Authors:  Elamin I E Abdelgadir; Mohamed M Hassanein; Alaaeldin M K Bashier; Sulaf Abdelaziz; Salwa Baki; Asma Chadli; Sara Askaoui; El Ansari Nawal; Ines S Slim; El Mghari Ghizlane; Khadija Hafidh; Fatheya Alawadi
Journal:  J Diabetes Metab Disord       Date:  2016-11-05

5.  Metabolic effects of Ramadan fasting in patients at high risk of cardiovascular diseases.

Authors:  K Beltaief; W Bouida; I Trabelsi; H Baccouche; M Sassi; Z Dridi; T Chakroun; I Hellara; R Boukef; M Hassine; F Addad; R Razgallah; I Khochtali; S Nouira
Journal:  Int J Gen Med       Date:  2019-07-15

6.  Instructions for kidney recipients and donors (In English for medical providers and in Arabic for patients and donors).

Authors:  Ziad Arabi; Basmeh Ghalib; Ibrahim Asmari; Mohammed Gafar; Syed Alam; Mohamad Abdulgadir; Ala AlShareef; Awatif Rashidi; Mohammed Alruwaymi; Abdulrahman Altheaby
Journal:  Avicenna J Med       Date:  2020-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.